TNSN03141A1 - Formulation pharmaceutique au gout masque et son procede de preparation - Google Patents
Formulation pharmaceutique au gout masque et son procede de preparationInfo
- Publication number
- TNSN03141A1 TNSN03141A1 TNPCT/FR2002/002158A TNSN03141A TNSN03141A1 TN SN03141 A1 TNSN03141 A1 TN SN03141A1 TN SN03141 A TNSN03141 A TN SN03141A TN SN03141 A1 TNSN03141 A1 TN SN03141A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- pharmaceutical formulation
- mask taste
- taste
- aqueous suspension
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000007900 aqueous suspension Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0108157A FR2826274B1 (fr) | 2001-06-21 | 2001-06-21 | Formulation pharmaceutique au gout masque et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN03141A1 true TNSN03141A1 (fr) | 2005-12-23 |
Family
ID=8864587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNPCT/FR2002/002158A TNSN03141A1 (fr) | 2001-06-21 | 2002-06-21 | Formulation pharmaceutique au gout masque et son procede de preparation |
Country Status (41)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| GB2419094A (en) * | 2004-10-12 | 2006-04-19 | Sandoz Ag | Pharmaceutical composition of unpleasnt tasing active substances |
| FR2882522B1 (fr) * | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
| US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
| US20060264386A1 (en) * | 2005-05-17 | 2006-11-23 | Rongqi Sun | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof |
| US20090011007A1 (en) * | 2006-02-03 | 2009-01-08 | Evonik Roehm Gmbh | Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water |
| US20100226979A1 (en) * | 2006-03-21 | 2010-09-09 | Jubilant Organosys Limited | Taste Masked Phamaceutical Composition for Oral Solid Dosage form and Process for Preparing the Same Using Magnesium Aluminium Silicate |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| KR100935893B1 (ko) * | 2007-09-11 | 2010-01-07 | 국방과학연구소 | 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법 |
| EP2214484A4 (en) | 2007-10-25 | 2013-01-02 | Cempra Pharmaceuticals Inc | PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS |
| BRPI0922382B1 (pt) | 2008-12-16 | 2019-06-18 | Carlsberg A/S | Material de polímero à base de celulose, recipiente para armazenamento de líquidos, material para armazenamento de alimentos e método para preparar o referido material |
| NZ700182A (en) | 2012-03-27 | 2017-02-24 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| DE102012014848A1 (de) * | 2012-07-27 | 2012-10-31 | Heilerde-Gesellschaft Luvos Just GmbH & Co. KG | Heilerde-Zubereitung |
| SG11201700827RA (en) * | 2014-08-05 | 2017-03-30 | Cempra Pharmaceuticals Inc | Powder oral suspension formulations of antibacterial agents |
| US10982177B2 (en) | 2017-09-18 | 2021-04-20 | The Clorox Company | Cleaning wipes with particular lotion retention and efficacy characteristics |
| CN114209661B (zh) * | 2022-02-21 | 2022-04-29 | 北京罗诺强施医药技术研发中心有限公司 | 呈细粒形式的固体药物组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2930409A1 (de) * | 1979-07-26 | 1981-02-12 | Bayer Ag | Spruehtrocknung von mikrokapseldispersionen |
| JPS63150220A (ja) * | 1986-12-15 | 1988-06-22 | Dainippon Pharmaceut Co Ltd | 経口用固形製剤の製造方法 |
| US4808411A (en) * | 1987-06-05 | 1989-02-28 | Abbott Laboratories | Antibiotic-polymer compositions |
| US5084278A (en) * | 1989-06-02 | 1992-01-28 | Nortec Development Associates, Inc. | Taste-masked pharmaceutical compositions |
| ZA945944B (en) * | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
| AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
| JP2001518490A (ja) * | 1997-10-03 | 2001-10-16 | エラン コーポレーシヨン ピーエルシー | 味遮蔽された製剤 |
| IN191239B (https=) * | 1999-06-11 | 2003-10-11 | Ranbaxy Lab Ltd | |
| US6555569B2 (en) * | 2000-03-07 | 2003-04-29 | Pfizer Inc. | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| JP4162992B2 (ja) * | 2000-08-22 | 2008-10-08 | バジリア ファルマスーチカ アーゲー | 抗菌活性を有する新規マクロライド |
-
2001
- 2001-06-21 FR FR0108157A patent/FR2826274B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-08 TW TW091109613A patent/TWI228049B/zh not_active IP Right Cessation
- 2002-05-09 JO JO200241A patent/JO2325B1/en active
- 2002-06-11 GT GT200200115A patent/GT200200115A/es unknown
- 2002-06-11 GT GT200200115AK patent/GT200200115AA/es unknown
- 2002-06-17 MY MYPI20022250A patent/MY134340A/en unknown
- 2002-06-18 PE PE2002000522A patent/PE20030201A1/es not_active Application Discontinuation
- 2002-06-18 UY UY27341A patent/UY27341A1/es not_active Application Discontinuation
- 2002-06-19 SV SV2002001098A patent/SV2003001098A/es not_active Application Discontinuation
- 2002-06-19 AR ARP020102300A patent/AR036096A1/es not_active Application Discontinuation
- 2002-06-19 PA PA20028548301A patent/PA8548301A1/es unknown
- 2002-06-21 CA CA2452239A patent/CA2452239C/fr not_active Expired - Fee Related
- 2002-06-21 IL IL15940402A patent/IL159404A0/xx active IP Right Grant
- 2002-06-21 AT AT02764922T patent/ATE290366T1/de active
- 2002-06-21 CN CNB028121465A patent/CN1239149C/zh not_active Expired - Fee Related
- 2002-06-21 MX MXPA03011756A patent/MXPA03011756A/es active IP Right Grant
- 2002-06-21 BR BRPI0208998A patent/BRPI0208998A2/pt not_active IP Right Cessation
- 2002-06-21 TN TNPCT/FR2002/002158A patent/TNSN03141A1/fr unknown
- 2002-06-21 NZ NZ530042A patent/NZ530042A/en not_active IP Right Cessation
- 2002-06-21 HR HR20031067A patent/HRP20031067B1/xx not_active IP Right Cessation
- 2002-06-21 EP EP02764922A patent/EP1401397B1/fr not_active Expired - Lifetime
- 2002-06-21 AP APAP/P/2003/002927A patent/AP1595A/en active
- 2002-06-21 PT PT02764922T patent/PT1401397E/pt unknown
- 2002-06-21 PL PL366803A patent/PL202090B1/pl unknown
- 2002-06-21 WO PCT/FR2002/002158 patent/WO2003000225A2/fr not_active Ceased
- 2002-06-21 HU HU0400799A patent/HUP0400799A3/hu unknown
- 2002-06-21 SK SK1592-2003A patent/SK285865B6/sk not_active IP Right Cessation
- 2002-06-21 ES ES02764922T patent/ES2236574T3/es not_active Expired - Lifetime
- 2002-06-21 JP JP2003506872A patent/JP4880871B2/ja not_active Expired - Fee Related
- 2002-06-21 CZ CZ20033441A patent/CZ299947B6/cs not_active IP Right Cessation
- 2002-06-21 DE DE60203178T patent/DE60203178T2/de not_active Expired - Lifetime
- 2002-06-21 AU AU2002329311A patent/AU2002329311B2/en not_active Ceased
- 2002-06-21 UA UA2004010425A patent/UA77960C2/uk unknown
- 2002-06-21 OA OA1200300340A patent/OA12635A/fr unknown
- 2002-06-21 EA EA200400061A patent/EA006016B1/ru not_active IP Right Cessation
-
2003
- 2003-12-05 ZA ZA2003/09479A patent/ZA200309479B/en unknown
- 2003-12-12 US US10/735,538 patent/US7138138B2/en not_active Expired - Lifetime
- 2003-12-15 NO NO20035581A patent/NO332258B1/no not_active IP Right Cessation
- 2003-12-16 BG BG108458A patent/BG66314B1/bg unknown
- 2003-12-16 MA MA27445A patent/MA27042A1/fr unknown
- 2003-12-16 IL IL159404A patent/IL159404A/en not_active IP Right Cessation
- 2003-12-18 EC EC2003004915A patent/ECSP034915A/es unknown
- 2003-12-19 CO CO03111139A patent/CO5540278A2/es active IP Right Grant
-
2006
- 2006-09-20 US US11/533,573 patent/US20070014857A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN03141A1 (fr) | Formulation pharmaceutique au gout masque et son procede de preparation | |
| Li et al. | Nano–bio interactions: biofilm‐targeted antibacterial nanomaterials | |
| Cardozo et al. | Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis | |
| MA28740B1 (fr) | Methodes de traitement d'infections endobronchiques | |
| WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
| NZ709754A (en) | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers | |
| EP2322146A3 (en) | Microcapsule formulations comprising two pharmaceutically active ingredients | |
| PL358103A1 (pl) | Hydrofilowe molekularne roztwory dyspersyjne karwedilolu | |
| NO20092662L (no) | Sammensetning med forlenget frigjoring og fremgangsmate for a produsere det samme | |
| CA2067228A1 (en) | Drug delivery system, method for preparing the same and use thereof | |
| TNSN03106A1 (fr) | Procede pour la production d'une composition pharmaceutique a faible dose ayant une distribution et activite medicamenteuse uniforme | |
| EP1852114A4 (en) | COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS | |
| WO2004017943A3 (en) | Non-vesicular cationic lipid formulations | |
| JP5715139B2 (ja) | 消化管に存在する望ましくない分子を特異的に吸着し得る医学製剤 | |
| AU776587B2 (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
| ATE390127T1 (de) | Universelle zusammensetzung zur kontrollierten wirkstoffabgabe enthaltend chitosan | |
| RU96120655A (ru) | Композиция для профилактики и лечения гриппа и орви | |
| Sharma et al. | Nanostrategies against rising antimicrobial resistance (AMR)-metallic nanoparticles as nanoweapon | |
| EP1634585A4 (en) | MEDICINAL PRODUCTS CONTAINING DELAYED MICROTEIL, PROCESS FOR ITS PREPARATION AND MICROPARTICLE CONTAINING PREPARATION | |
| EP1563836A4 (en) | ACTIVE SUBSTANCE FOR INHIBITING MATRIX METALOPROTEASE-9 PRODUCTION | |
| NO940064L (no) | Öyepreparat på polyakrylsyrebasis | |
| NO20010507L (no) | Farmasoytisk sammensetning med antitumoraktivitet pa basis av karboplatin | |
| WO2000025765A3 (de) | Wässrige arzneimittelformulierung zur oralen applikation | |
| Niedrist | A granular hydrogel platform for periodontal applications | |
| WO2002020464A8 (en) | Benzene tricarboxylic acid amides as insulin receptor activators |